NO990547L - Farmas°ytiske produkter for behandling og forhindring av sykdommer forbundet med funksjonsfeil i vaskulµre endotelceller - Google Patents

Farmas°ytiske produkter for behandling og forhindring av sykdommer forbundet med funksjonsfeil i vaskulµre endotelceller

Info

Publication number
NO990547L
NO990547L NO990547A NO990547A NO990547L NO 990547 L NO990547 L NO 990547L NO 990547 A NO990547 A NO 990547A NO 990547 A NO990547 A NO 990547A NO 990547 L NO990547 L NO 990547L
Authority
NO
Norway
Prior art keywords
pct
endothelial cells
malfunction
prevention
treatment
Prior art date
Application number
NO990547A
Other languages
English (en)
Other versions
NO325109B1 (no
NO990547D0 (no
Inventor
Andrea Jednakovits
Laszlo Ueroegdi
Ede Marvanyos
Mihaly Barabas
Istvan Kurucz
Erno Bacsy
Laszlo Koranyi
Sandor Erdo
Gyoergy Dorman
Marta Vitai
Gyoergy Schmidt
Marta Sinka
Original Assignee
Biorex Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9602204A external-priority patent/HUP9602204D0/hu
Priority claimed from HU9701349A external-priority patent/HUP9701349A1/hu
Application filed by Biorex Kutato Fejlesztoe Kft filed Critical Biorex Kutato Fejlesztoe Kft
Publication of NO990547D0 publication Critical patent/NO990547D0/no
Publication of NO990547L publication Critical patent/NO990547L/no
Publication of NO325109B1 publication Critical patent/NO325109B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19990547A 1996-08-09 1999-02-05 Anvendelse av hydroksylamin-derivater for fremstilling av medisiner for behandling av sykdommer som skyldes skader pa endotelcellene NO325109B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9602204A HUP9602204D0 (en) 1996-08-09 1996-08-09 Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells
HU9701349A HUP9701349A1 (hu) 1997-08-04 1997-08-04 Gyógyászati készítmények a vaszkuláris endoteliális sejtek rendellenes működésével összefüggő betegségek gyógyítására vagy megelőzésére
PCT/HU1997/000044 WO1998006400A2 (en) 1996-08-09 1997-08-06 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells

Publications (3)

Publication Number Publication Date
NO990547D0 NO990547D0 (no) 1999-02-05
NO990547L true NO990547L (no) 1999-03-25
NO325109B1 NO325109B1 (no) 2008-02-04

Family

ID=90014231

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990547A NO325109B1 (no) 1996-08-09 1999-02-05 Anvendelse av hydroksylamin-derivater for fremstilling av medisiner for behandling av sykdommer som skyldes skader pa endotelcellene

Country Status (20)

Country Link
US (1) US6143741A (no)
EP (1) EP0966283B1 (no)
JP (1) JP2001504446A (no)
AT (1) ATE329592T1 (no)
AU (1) AU739614B2 (no)
BG (1) BG64456B1 (no)
CA (1) CA2262997C (no)
CZ (1) CZ298542B6 (no)
DE (1) DE69736130T2 (no)
DK (1) DK0966283T3 (no)
EE (1) EE04044B1 (no)
ES (1) ES2267148T3 (no)
HK (1) HK1025506A1 (no)
IL (1) IL128256A (no)
NO (1) NO325109B1 (no)
PT (1) PT966283E (no)
RS (1) RS49719B (no)
SK (1) SK284301B6 (no)
UA (1) UA64716C2 (no)
WO (1) WO1998006400A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9701081D0 (en) 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
HU226617B1 (en) * 1998-12-14 2009-04-28 Cytrx Corp Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
KR20040089102A (ko) * 2002-01-11 2004-10-20 비오렉스 쿠타토 에쉬 훼레스테 에르테 카르복사미딘 유도체 및 혈관 질환의 치료에서의 이들 용도
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
US20080227813A1 (en) * 2006-09-26 2008-09-18 Jack Raymond Barber Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
WO2008070010A2 (en) * 2006-12-01 2008-06-12 Cytrx Corporation Hydroxylamine derivatives for the treatment of stroke
TW200901958A (en) * 2007-05-04 2009-01-16 Cytrx Corp Diabetic wound healing
JP5429865B2 (ja) * 2009-09-15 2014-02-26 学校法人日本大学 生体外創傷治癒試験用用具または創傷作製方法
HUP1100535A2 (en) * 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
US9802927B2 (en) 2015-06-10 2017-10-31 Denali Therapeutics, Inc. Oxadiazine compounds and methods of use thereof
IL303026A (en) 2020-11-19 2023-07-01 Zevra Denmark As Processes for preparing arimoclomol citrate and its intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
GB9017351D0 (en) * 1990-08-08 1990-09-19 Wellcome Found Medicaments for treatment of atherosclerosis
ES2123252T3 (es) * 1994-05-06 1999-01-01 Biorex Kutato Fejlesztoe Kft Nuevos derivados de acido hidroximico, composiciones farmaceuticas que los contienen y procedimiento para su preparacion.
HU218480B (hu) * 1995-06-15 2000-09-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására

Also Published As

Publication number Publication date
DK0966283T3 (da) 2006-10-09
PT966283E (pt) 2006-08-31
EP0966283A2 (en) 1999-12-29
SK15499A3 (en) 2000-02-14
AU3704997A (en) 1998-03-06
EE04044B1 (et) 2003-06-16
RS49719B (sr) 2007-12-31
IL128256A0 (en) 2000-02-17
SK284301B6 (sk) 2005-01-03
DE69736130T2 (de) 2007-01-04
AU739614B2 (en) 2001-10-18
CZ43599A3 (cs) 1999-07-14
BG64456B1 (bg) 2005-03-31
DE69736130D1 (de) 2006-07-27
IL128256A (en) 2004-05-12
WO1998006400A2 (en) 1998-02-19
CA2262997A1 (en) 1998-02-19
CA2262997C (en) 2008-07-29
US6143741A (en) 2000-11-07
NO325109B1 (no) 2008-02-04
UA64716C2 (en) 2004-03-15
ES2267148T3 (es) 2007-03-01
YU5199A (sh) 2000-10-30
NO990547D0 (no) 1999-02-05
CZ298542B6 (cs) 2007-10-31
BG103194A (en) 1999-09-30
EE9900044A (et) 1999-08-16
JP2001504446A (ja) 2001-04-03
ATE329592T1 (de) 2006-07-15
HK1025506A1 (en) 2000-11-17
EP0966283B1 (en) 2006-06-14
WO1998006400A3 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
NO20052739L (no) CCR5-antagonister som medikamenter
NO990547L (no) Farmas°ytiske produkter for behandling og forhindring av sykdommer forbundet med funksjonsfeil i vaskulµre endotelceller
YU69991A (sh) Derivati piridina
HUP0301749A2 (hu) Acilfenil-karbamid-származékok, eljárás az elżállításukra és gyógyszerkénti alkalmazásuk
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
BG101118A (en) Therapeutical compounds
NO972980D0 (no) Anvendelse av nebivolol som et anti-aterogent middel
DE60324014D1 (de) Heterocyclische verbindungen alsccr5-antagonisten
DE69019533D1 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
DE59606784D1 (de) Verwendung von boswelliasäure und ihren derivaten zur hemmung der normalen und gesteigerten leukozytenelastase- oder plasminaktivität
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
GEP20053617B (en) Bridged Piperazine Derivatives
DE3778008D1 (de) Ketonderivate als arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
DE69525649D1 (de) Lamotrigin haltiges arzneimittel
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
DK0674515T3 (da) Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8
LV11728A (lv) Farmaceitiska kompozicija
DK0609336T3 (da) Anvendelse af prostacyclin-derivater til forebyggelse eller behandling af lidelser i mikrocirkulationssystemet ved administ
DE3879688D1 (de) Anti-retrovirales arzneimittel.
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
HK1044467A1 (en) Use of polycyclic thiazole systems for producing medicaments for preventing or treating obesity
DK0678089T3 (da) N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
ATE190845T1 (de) Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen
HUP0300043A2 (en) Method and composition for the treatment of pain

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees